Navigation Links
Medication effective for acute liver failure in early stages of disease
Date:10/7/2009

val three weeks after they were placed on treatment.

Researchers found that 52 percent of acute liver failure patients in mild to moderate comas survived when treated with NAC, compared to just 30 percent of those treated with only a placebo. In patients experiencing more severe coma, treatment with NAC did not result in a significant difference in survival rates.

"That makes sense because patients with advanced comas typically die or get a transplant within a few days," said Dr. Lee, principal investigator of the Acute Liver Failure Study Group, a national consortium of liver centers formed in 1997 to increase research into the rare disease.

"This study establishes NAC as a treatment for non-acetaminophen acute liver failure patients in mild to moderate coma and provides the first glimmer of hope that something can help these direly ill patients," Dr. Lee said.

He said he will continue to study NAC as a therapy for acute liver failure not caused by acetaminophen poisoning to determine optimal dosing and duration.


'/>"/>

Contact: LaKisha Ladson
lakisha.ladson@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Many Kids Suffer Medication Side Effects: Study
2. New Source of Information on Eczema Medications
3. Diabetes Medications Dont Lower Inflammation
4. Patients Get Free Text or Email Prescription Medication Reminders From FreeRxReminder.com
5. Medications That Lower Breast Cancer Risk Carry Other Dangers
6. Meda Introduces EDLUAR(TM), the First and Only Sublingual Tablet That Contains the Most Prescribed Sleep Medication, Zolpidem Tartrate
7. Center for Technology and Aging Releases Guidelines for $500,000 Medication Optimization Diffusion Grants Program
8. CVS Caremark Data Finds More than 50 Percent of Adults 45-years and Younger are not Adherent to Cholesterol Lowering Medications
9. Medication Review May Help With Heart Failure
10. Misuse of Pain Medication Draws Heightened Concerns
11. Digitek Medication Recalled Due to Risk of Digitalis Toxicity

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medication effective for acute liver failure in early stages of disease
Medication effective for acute liver failure in early stages of disease
(Date:11/22/2009)... amount of television viewed by many young childre...mates of early childhood screen time, with those i...on average than those in center-based daycares. T...hild care settings in more than 20 years. The stu...rams in four states, and was guided by lead resear...
(Date:11/22/2009)...ce, bacteria are abundant, diverse and constant, b...niversity of California, San Diego School of Medic...he skin surface trigger a pathway that prevents ex...s are actually good for us," said Richard L. Gallo...hief of UCSD,s Division of Dermatology and the Der...
(Date:11/22/2009)... The holiday season is filled with get-togethe... joyous. It can also be stressful and tiring at ti..., fatigue, and high fat foods -- factors that can,...hy the National Foundation for Cancer Research has...p ensure a happier, more healthful holiday season,...
(Date:11/21/2009)... bill provides for an unprecedented expansion of f...t if it is not for preserving and protecting human...ated." Charmaine Yoest ,, WASHINGTON, Nov. 2...Life Action President and CEO Dr. Charmaine Yoest ...sing the following statement: ,, "This was a p...
(Date:11/21/2009)... NH based medical credentialing software compa...to form a partnerhsip with Amerinet, Inc., the lea...ip will help to transform quality care within the ...us) November 21, 2009 -- ISG Group, LLC, doing bus...reement with Amerinet Inc., a leading national hea...
Breaking Medicine News(10 mins):Health News:Daycare may double TV time for young children, study finds 2Health News:Daycare may double TV time for young children, study finds 3Health News:Daycare may double TV time for young children, study finds 4Health News:Surface bacteria maintain skin's healthy balance 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2
...k of knowledge of health risks posed by long-term...) -- As cell phone technology and use continues to...s known about the potential health risks associate...subject to high occupational exposure -- the repor...
...Researchers at the University of Pennsylvania Scho...hemical cargo in nerve cells react differently whe...tant role in Alzheimers disease. , Dynein and ki...d bump to regulate protein traffic, the group foun...
... How to Safely Enhance Athletic Performance, LAKE...e,for athletes, coaches, trainers and parents, the...ement.com ) aims to provide individuals with infor... Informed-Choice LLC, a,not-for-profit partnership...
...an. 17 Following is a,media statement attributabl... New Jersey Hospital Association:, "NJHA applauds...t,Safety Initiative report. This is a valuable doc...ement efforts. The confidential reporting and,coll...
...nwide Campaign Challenging U.S. to Close the Gaps ...al, COLUMBUS, Ohio, Jan. 17 On Tuesday, January ...Cure will host two events to,launch Ohio,s partici...an others., (Logo: http://www.newscom.com/cgi-bi...
...Jan. 17 Immunosyn,Corporation (OTC Bulletin Board...formal "Proof of Concept Trial" for the biopharmac... Europe for treatment of Diabetic Ulcers., The Bo...rtner and largest shareholder. Argyll Biotechnolog...
Other Medicine News:Health News:Report Urges More Research Into Cell Phones 2Health News:Report Urges More Research Into Cell Phones 3Health News:Alzheimer's molecule is a smart speed bump on the nerve-cell transport highway 2Health News:New Blog Provides Forum for Discussions on Supplement Safety 2Health News:Susan G. Komen for the Cure, U.S. Congressman Pat Tiberi, Ohio Senator Tom Niehaus, and OhioHealth Riverside Breast Health Center Call for Action on Breast Cancer 2Health News:Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019 2Health News:Immunosyn Announces the Successful Completion of First Phase 'Proof of Concept Trial' in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019 3
(Date:11/20/2009)...PHIS, Tenn., Nov. 20 S...ision is pleased to announce the signing of a tech... Department of Defense that may lead to the creati...utionize the treatment of the limbs of soldiers wh...he Defense Advanced Research Projects Agency (DARP...
(Date:11/19/2009)...BIRMINGHAM, Ala., Nov. 19 /PRNewswire-FirstCall/ -...today announced the pricing of a public offering o...r share, resulting in gross proceeds of $48.75 mil...ryst pursuant to an effective shelf registration s...Exchange Commission. BioCryst has also granted th...
(Date:11/19/2009)... TAINAN, Taiwan, Nov. 19 /PRNewswire-Asia/ -- S...rmaceutical ingredients (APIs), announced that its...Safety Certification from,SafeBridge(R) Consultant...mpetency and proficiency in the safe handling of p...d applies to specific laboratories and,production ...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3ScinoPharm Announces SafeBridge Potent Compound Safety Certification 2Congress Appeals to Obama Administration Thailand 3A Stop Hmong Returns to Laos 49312 1Congress Appeals to Obama Administration Thailand 3A Stop Hmong Returns to Laos 49312 2NIST discovers how strain at grain boundaries suppresses high temperature superconductivity 12683 1NIST discovers how strain at grain boundaries suppresses high temperature superconductivity 12683 2Epilepsy Services on the Chopping Block 49309 1Epilepsy Services on the Chopping Block 49309 2
... Both in the Short and Long Term ...aZeneca (NYSE:,AZN) today announced new study data...-Release Tablets for the treatment of major depres...er (GAD) in adult patients.,The results from the s...eting of the American Psychiatric Association (APA...
...eep children,healthy, they also lead to more produ...save more money, according to Dr. David E. Bloom, ...Health., Bloom, who has studied the economic impa... the keynote speaker at the 11th Annual Conference...ndation for Infectious,Diseases (NFID). The confer...
Other Medicine Technology:New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 2New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 3New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 4New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 5New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 6New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 7New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 8New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 9New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 10New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 11New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 12New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 13New Data on SEROQUEL XR(TM) in Treatment of Both Major Depressive Disorder and Generalized Anxiety Disorder Presented at APA Annual Meeting 14Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 2Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 3Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 4Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 5Annual Conference on Vaccine Research to Highlight Not Only Health Benefits But Also Economic Gains 6
...255 is a portable, waterproof system for routine p...nts. Temperature compensated pH results can be obt...a 3-in-1 electrode. • Fast and easy one-, two...atic buffer recognition for five buffers (pH 1.68,...
...265 is a highly accurate portable, waterproof syst...easurements. Temperature compensated pH results ca...ATC) or a 3-in-1 electrode. • This GLP/GMP co...nect to a printer or a computer. Up to 100 data se...
...e doors, 8 shelves. Over-sized compressor. Triple...cent interior lighting. Self-Contained System No ...Full One Year Warranty on Parts & Labor and an Add...lable as a chromatography unit which includes two ...
...e doors, 8 shelves. Over-sized compressor. Trip...escent interior lighting. Self-Contained System N... Full One Year Warranty on Parts & Labor and an A...ailable as a chromatography unit which includes tw...
Medicine Products: